Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
2.730
-0.040 (-1.44%)
Nov 21, 2024, 4:00 PM EST - Market closed
Trevi Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$9.13
Upside
+234.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +193.04% | Nov 8, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +669.23% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +119.78% | Oct 22, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +669.23% | Oct 21, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +119.78% | Oct 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +193.04% | Oct 4, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +669.23% | Oct 4, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +669.23% | Sep 17, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $7 | Buy | Initiates | $7 | +156.41% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +119.78% | Aug 30, 2024 |
| Raymond James | Raymond James | Buy Initiates $9 | Buy | Initiates | $9 | +229.67% | Aug 30, 2024 |
| EF Hutton | EF Hutton | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +669.23% | Aug 19, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +156.41% | Jun 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +193.04% | May 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +193.04% | Apr 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +193.04% | Mar 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.